Sign Up Today and Learn More About Lassen Therapeutics Stock
Invest in or calculate the value of your shares in Lassen Therapeutics or other pre-IPO companies through EquityZen's platform.
Lassen Therapeutics Stock (LATH)
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
About Lassen Therapeutics Stock
Founded
2018
Headquarters
San Diego, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Lassen Therapeutics Press Mentions
Stay in the know about the latest news on Lassen Therapeutics
Growing IL-18 field looks to enhance cell therapies via decoy evasion
biocentury • Jun 05, 2024
Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission
fiercebiotech • May 05, 2024
Lassen Therapeutics Lands $85M Series B
sdbj • Jan 20, 2024
Lassen Therapeutics Closes $85M Series B Financing
finsmes • Dec 21, 2023
US gas consumption to dip next year amid high inflation ...
ca • Dec 21, 2023
Lassen Therapeutics Management
Leadership team at Lassen Therapeutics
Founder & CEO
Mark Barrett
Co-Founder & Chief Scientific Officer
David King
Join now and verify your accreditation status to gain access to:
- Lassen Therapeutics current valuation
- Lassen Therapeutics stock price
- Available deals in Lassen Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Lassen Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Lassen Therapeutics through EquityZen funds. These investments are made available by existing Lassen Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Lassen Therapeutics stock?
Shareholders can sell their Lassen Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
